IceCure Medical Ltd (ICCM)
NASDAQ: ICCM
· Real-Time Price · USD
1.03
0.00 (0.00%)
At close: Sep 26, 2025, 3:59 PM
1.03
-0.48%
After-hours: Sep 26, 2025, 07:37 PM EDT
0.00% (1D)
| Bid | 1.01 |
| Market Cap | 71.1M |
| Revenue (ttm) | 2.79M |
| Net Income (ttm) | -15.58M |
| EPS (ttm) | -0.27 |
| PE Ratio (ttm) | -3.83 |
| Forward PE | -5.83 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 1.04 |
| Volume | 333,754 |
| Avg. Volume (20D) | 1,774,490 |
| Open | 1.03 |
| Previous Close | 1.03 |
| Day's Range | 1.02 - 1.04 |
| 52-Week Range | 0.48 - 1.66 |
| Beta | 2.48 |
| Ex-Dividend Date | n/a |
About ICCM
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ICCM
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ICCM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsIceCure Medical Ltd is scheduled to release its earnings on
Nov 25, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
6 months ago
-15.54%
IceCure Medical shares are trading lower. The comp...
Unlock content with
Pro Subscription
11 months ago
+18.18%
IceCure Medical shares are trading higher after the company announced that a large number of public comments have been posted from key stakeholders ahead of the FDA Medical Device Advisory Committee Panel for marketing authorization of ProSens® cryoablation in early-stage low risk breast cancer.
